Secretory IgA: Designed for anti-microbial defense

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Brandtzaeg, Per ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibodies; Commensals; GALT; Germinal centers; MALT; Mucosa; NALT; Pathogens

Indexed keywords

ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 17; PATTERN RECOGNITION RECEPTOR; SECRETORY COMPONENT; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR;

ANTIBODY RESPONSE; ANTIMICROBIAL ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL MIGRATION; CELLULAR IMMUNITY; CROSS REACTION; DEFENSE MECHANISM; ENDOCYTOSIS; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOLOGICAL MEMORY; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE HOMING; MARGINAL ZONE LYMPHOMA; NONHUMAN; PATHOGENESIS;

EID: 84883713293     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00222     Document Type: Article

References (200)

1. Besredka A. De la vaccination contre les états typhoides par la voie buccale. Ann Inst Pasteur (1919) 33:882-903.
2. Davies A. An investigation into the serological properties of dysentery stools. Lancet (1922) 2:1009-12. doi:10.1016/S0140-6736(01)16832-7
3. Besredka A. Local Immunization. Baltimore: Williams & Wilkins Company (1927).
4. Pierce AE. Specific antibodies at mucous surfaces. Vet Rev Annot (1959) 5:17-36.
5. Ellison SA, Mashimo PA, Mandel ID. Immunochemical studies of human saliva. I. The demonstration of serum proteins in whole and parotid saliva. J Dent Res (1960) 39:892-8. doi:10.1177/00220345600390052301
6. Hanson LÅ, Brandtzaeg P. The discovery of secretory IgA and the mucosal immune system. Immunol Today (1993) 14:416-7. doi:10.1016/0167-5699(93)90146-C
7. Tomasi TB, Tan EM, Solomon A, Prendergast RA. Characteristics of an immune system common to certain external secretions. J Exp Med (1965) 121:101-24. doi:10.1084/jem.121.1.101
8. Crabbé PA, Carbonara AO, Heremans JF. The normal human intestinal mucosa as a major source of plasma cells containing Gamma;A-immunoglobulin. Lab Invest (1965) 14:235-48.
9. Brandtzaeg P. Two types of IgA immunocytes in man. Nature New Biol (1973) 243:142-3.
10. Brandtzaeg P. Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature (1974) 252:418-20. doi:10.1038/252418a0
11. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Immunoglobulin M: local synthesis and selective secretion in patients with immunoglobulin A deficiency. Science (1968) 160:789-91. doi:10.1126/science.160.3829.789
12. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol Suppl (1970) 12:1-83.
13. Brandtzaeg P. Human secretory immunoglobulin M. An immunochemical and immunohistochemical study. Immunology (1975) 29:559-70.
14. Nagura H, Brandtzaeg P, Nakane PK, Brown WR. Ultrastructural localization of J chain in human intestinal mucosa. J Immunol (1979) 123:1044-50.
15. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology (1974) 26:1101-4.
16. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Differential localization of free and bound SC in secretory epithelial cells. J Immunol (1974) 112:1553-9.
17. Brandtzaeg P. Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol (1985) 22:111-46. doi:10.1111/j.1365-3083.1985.tb01866.x
18. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature (1984) 311:71-3. doi:10.1038/311071a0
19. Krajci P, Grzeschik KH, Geurts van Kessel AHM, Olaisen B, Brandtzaeg P. The human transmembrane secretory component (poly-Ig receptor): molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization. Hum Genet (1991) 87:642-8. doi:10.1007/BF00201717
20. Johansen F-E, and Brandtzaeg P. Transcriptional regulation of the mucosal IgA system. Trends Immunol (2004) 25:150-7. doi:10.1016/j.it.2004.01.001
21. Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajci K, Kvale D, Scott H, et al. Epithelial expression of HLA secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci (1992) 664:157-79. doi:10.1111/j.1749-6632.1992.tb39758.x
22. Piskurich JF, Youngman KR, Phillips KM, Hempen PM, Blanchard MH, France JA, et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-Gamma;. Mol Immunol (1997) 34:75-91. doi:10.1016/S0161-5890(96)00079-X
23. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol (2012) 189:4666-73. doi:10.4049/jimmunol.1200955
24. Brandtzaeg P. Gate-keeper function of the intestinal epithelium. Benef Microbes (2013) 4:67-82. doi:10.3920/BM2012.0024
25. Sletten K, Christensen TB, Brandtzaeg P. Human secretory component - III. Carbohydrates, amino acids and N-terminal sequence. Immunochemistry (1975) 12:783-5. doi:10.1016/0019-2791(75)90230-X
26. Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol (2010) 5:817-29. doi:10.2217/fmb.10.39
27. Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol (2008) 1:31-7. doi:10.1038/mi.2007.9
28. Brandtzaeg P. Human secretory immunoglobulins. 4. Quantitation of free secretory piece. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 79:189-203.
29. Norderhaug IN, Johansen F-E, Schjerven H, Brandtzaeg P. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol (1999) 19:481-508.
30. Brandtzaeg P. Human secretory component - VI. Immunoglobulin-binding properities. Immunochemistry (1977) 14:179-88. doi:10.1016/0019-2791(77)90192-6
31. Vaerman J-P, Langendries AE, Giffroy DA, Kaetzel CS, Fiani CM, Moro I, et al. Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA. Eur J Immunol (1998) 28:171-82. doi:10.1002/(SICI)1521-4141(199801)28:01<171::AID-IMMU171>3.0.CO;2-\#
32. Johansen F-E, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol (2001) 167:5185-92.
33. Braathen R, Hohman VS, Brandtzaeg P, Johansen FE. Secretory antibody formation: conserved binding interactions between J chain and polymeric Ig receptor from humans and amphibians. J Immunol (2007) 178:1589-97.
34. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev (2005) 206:32-63. doi:10.1111/j.0105-2896.2005.00283.x
35. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science (1996) 272:54-60.
36. Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol (2000) 52:240-8. doi:10.1046/j.1365-3083.2000.00790.x
37. Brandtzaeg P, Berdal P. J chain in malignant human IgG immunocytes. Scand J Immunol (1975) 4:403-7. doi:10.1111/j.1365-3083.1975.tb02643.x
38. Mosmann TR, Gravel Y, Williamson AR, Baumal R. Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol (1978) 8:94-101. doi:10.1002/eji.1830080205
39. Natvig IB, Johansen FE, Nordeng TW, Haraldsen G, Brandtzaeg P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol (1997) 159:4330-40.
40. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS (1996) 104:321-38. doi:10.1111/j.1699-0463.1996.tb00724.x
41. Bonner A, Almogren A, Furtado PB, Kerr MA, Perkins SJ. The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses. J Biol Chem (2009) 284:5077-87. doi:10.1074/jbc.M807529200
42. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 136:3631-5.
43. Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology (1995) 109:819-25. doi:10.1016/0016-5085(95)90389-5
44. Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol (1991) 83:203-9. doi:10.1111/j.1365-2249.1991.tb05615.x
45. Brandtzaeg P. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells. Mol Immunol (1983) 20:941-66. doi:10.1016/0161-5890(83)90036-6
46. Bonner A, Almogren A, Furtado PB, Kerr MA, Perkins SJ. Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity. Mucosal Immunol (2009) 2:74-84. doi:10.1038/mi.2008.68
47. Brandtzaeg P. Immunohistochemical studies of various aspects of glandular immunoglobulin transport in man. Histochem J (1977) 9:553-72. doi:10.1007/BF01002902
48. Korsrud FR, Brandtzaeg P. Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component and secretory immunoglobulins by paired immunofluorescence staining. J Histochem Cytochem (1982) 20:657-66. doi:10.1177/30.7.6179983
49. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. Gastroenterology (1984) 86:402-12.
50. Brown WR, Smith PD, Lee E, McCalmon RT, Nagura H. A search for an enriched source of polymeric IgA in human thoracic duct lymph, portal vein blood and aortic blood. Clin Exp Immunol (1982) 48:85-90.
51. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol (2009) 70:505-15. doi:10.1111/j.1365-3083.2009.02319.x
52. Duc M, Johansen FE, Corthésy B. Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors. J Biol Chem (2010) 285:953-60. doi:10.1074/jbc.M109.059220
53. Brown TA, Mestecky J. Immunoglobulin A sublass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun (1985) 49:459-62.
54. Mansa B, Kilian M. Retained antigen-binding activity of Fab fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease. Infect Immun (1986) 52:171-174.
55. Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci U S A (2003) 100:4215-20. doi:10.1073/pnas.0637469100
56. Taylor HP, Dimmock NJ. Mechanism of neutralization of influenzae virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med (1985) 161:198-209.
57. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Adsorption of immunoglobulin A onto oral bacteria in vivo. J Bacteriol (1968) 96:242-9.
58. Christensen P, Oxelius V-A. A reaction between some streptococci and IgA myeloma proteins. Acta Pathol Microbiol Scand C (1975) 83:184-188.
59. Bollinger RR, Everett ML, Wahl SD, Lee YH, Orndorff PE, Parker W. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol (2006) 43:378-87. doi:10.1016/j.molimm.2005.02.013
60. Murthy AK, Chaganty BK, Troutman T, Guentzel MN, Yu JJ, Ali SK, et al. Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation. PLoS ONE (2011) 6:e16847. doi:10.1371/journal.pone.0016847
61. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol (1998) 160:1219-23.
62. Biesbrock AR, Reddy MS, Levine MJ. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 59:3492-3497.
63. Bonner A, Furtado PB, Almogren A, Kerr MA, Perkins SJ. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy. J Immunol (2008) 180:1008-18.
64. Quan C, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible immune barrier in humans. Infect Immun (1997) 65:3997-4004.
65. Brandtzaeg P. The gut as communicator between environment and host: immunological consequences. Eur J Pharmacol (2011) 668(Suppl 1):S16-32. doi:10.1016/j.ejphar.2011.07.006
66. Källenius G, Pawlowski A, Brandtzaeg P, Svenson S. Should a new tuberculosis vaccine be administered intranasally? Tuberculosis (Edinb) (2007) 87:257-66. doi:10.1016/j.tube.2006.12.006
67. Brandtzaeg P. Mucosal immunization: relevance to protection against tuberculosis? Third Global Forum, Cape Town: TB Vaccines (2013). 17 p. [Conference Programme and Abstracts].
68. Johansen FE, Pekna M, Norderhaug IN, Haneberg B, Hietala MA, Krajci P, et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med (1999) 190:915-22. doi:10.1084/jem.190.7.915
69. Tjärnlund A, Rodríguez A, Cardona PJ, Guirado E, Ivanyi J, Singh M, et al. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int Immunol (2006) 18:807-16. doi:10.1093/intimm/dxl017
70. Alvarez N, Otero O, Camacho F, Borrero R, Tirado Y, Puig A, et al. Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection. BMC Immunol (2013) 14(Suppl 1):S3. doi:10.1186/1471-2172-14-S1-S3
71. Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest (2010) 39(4-5):303-55. [Erratum in: Immunol. Invest. 2010; 39, 780]. doi:10.3109/08820131003680369
72. Agnello D, Denimal D, Lavaux A, Blondeau-Germe L, Lu B, Gerard NP, et al. Intrarectal immunization and IgA antibody-secreting cell homing to the small intestine. J Immunol (2013) 190:4836-47. doi:10.4049/jimmunol.1202979
73. Mestecky J, McGhee JR, Arnold RR, Michalek SM, Prince SJ, Babb JL. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 61:731-737.
74. Weisz-Carrington P, Roux ME, McWilliams M, Phillips-Quagliata JM, Lamm ME. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J Immunol (1979) 123:1705-1708.
75. Jackson DE, Lally ET, Nakamura MC, Montgomery PC. Migration of IgA-bearing lymphocytes into salivary glands. Cell Immunol (1981) 63:203-209.
76. Czerkinsky C, Svennerholm AM, Quiding M, Jonsson R, Holmgren J. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun (1991) 59:996-1001.
77. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol (2003) 67(Suppl 1):S69-76. doi:10.1016/j.ijporl.2003.08.018 [International Congress Series (ICS) 1254: 89-99, 2003 (Elsevier)].
78. Brandtzaeg P. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med (2011) 183:1595-604. doi:10.1164/rccm.201011-1783OC
79. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol (2004) 4:699-710. doi:10.1038/nri1439
80. He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 26:812-26. doi:10.1016/j.immuni.2007.04.014
81. Sun Y, Shi W, Yang JY, Zhou DH, Chen YQ, Zhang Y, et al. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J Dent Res (2012) 91:941-7. doi:10.1177/0022034512457684
82. Quiding-Järbrink M, Granstr̈m G, Nordström I, Holmgren J, Czerkinsky C. Induction of compartmentalized B-cell responses in human tonsils. Infect Immun (1995) 63:853-7.
83. Stoltenberg L, Vege A, Saugstad OD, Rognum TO. Changes in the concentration and distribution of immunoglobulin-producing cells in SIDS palatine tonsils. Pediatr Allergy Immunol (1995) 6:48-55.
84. Thrane P, Rognum TO, Brandtzaeg P. Increased immune response in upper respiratory and digestive tracts in SIDS. Lancet (1990) 335:229-30. doi:10.1016/0140-6736(90)90325-Y
85. Gleeson M, Clancy RL, Cripps AW. Mucosal immune response in a case of sudden infant death syndrome. Pediatr Res (1993) 33:554-556.
86. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today (1999) 20:383-4. doi:10.1016/S0167-5699(99)01498-X
87. Johansen F-E, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood (2005) 106:593-600. doi:10.1182/blood-2004-12-4630
88. Czerkinsky C, Cuburu N, Kweon MN, Anjuere F, Holmgren J. Sublingual vaccination. Hum Vaccin (2011) 7:110-4. doi:10.4161/hv.7.1.13739
89. Kweon MN. Sublingual mucosa: a new vaccination route for systemic and mucosal immunity. Cytokine (2011) 54:1-5. doi:10.1016/j.cyto.2010.12.014
90. Kulis M, Saba K, Kim EH, Bird JA, Kamilaris N, Vickery BP, et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol (2012) 129:1159-62. doi:10.1016/j.jaci.2011.11.045
91. Ostergaard PA. IgA levels and carrier rate of pathogenic bacteria in 27 children previously tonsillectomized. Acta Pathol Microbiol Scand C (1977) 85:178-186.
92. Hess M, Kugler J, Haake D, Lamprecht J. Reduced concentration of secretory IgA indicates changes of local immunity in children with adenoid hyperplasia and secretory otitis media. ORL J Otorhinolaryngol Relat Spec (1991) 53:339-341.
93. Gommerman JL, Mackay F, Donskoy E, Meier W, Martin P, Browning JL. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest (2002) 110:1359-69. doi:10.1172/JCI15975
94. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J Exp Med (1998) 187:1009-1018.
95. Tumanov A, Kuprash D, Lagarkova M, Grivennikov S, Abe K, Shakhov A, et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity (2002) 17:239-50. doi:10.1016/S1074-7613(02)00397-7
96. Tumanov AV, Kuprash DV, Mach JA, Nedospasov SA, Chervonsky AV. Lymphotoxin and TNF produced by B cells are dispensable for maintenance of the follicle-associated epithelium but are required for development of lymphoid follicles in the Peyer's patches. J Immunol (2004) 173:86-91.
97. Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol (1998) 10:289-297.
98. Liu Y-J, and Arpin C. Germinal center development. Immunol Rev (1997) 156:111-126.
99. MacLennan ICM, Gulbranson-Judge A, Toellner KM, Casamayor-Palleja M, Chan E, Sze DM, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev (1997) 156:53-66.
100. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science (1998) 281:96-99.
101. Pereira JP, Kelly LM, Xu Y, Cyster JG. EBI2 mediates B cell segregation between the outer and centre follicle. Nature (2009) 460:1122-6. doi:10.1038/nature08226
102. Gatto D, Wood K, Brink R. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J Immunol (2011) 187:4621-8. doi:10.4049/jimmunol.1101542
103. Schwickert TA, Victora GD, Fooksman DR, Kamphorst AO, Mugnier MR, Gitlin AD, et al. A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J Exp Med (2011) 208:1243-52. doi:10.1084/jem.20102477
104. Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu Y-J. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med (1997) 185:563-71.
105. Pereira JP, Kelly LM, Cyster JG. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int Immunol (2010) 22:413-9. doi:10.1093/intimm/dxq047
106. Kraal G. Antigens take the shuttle. Nat Immunol (2008) 9:11-2. doi:10.1038/ni0108-11
107. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 95:10089-10093.
108. Medina F, Segundo C, Campos-Caro A, Salcedo I, García-Poley A, Brieva JA. Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells. Gut (2003) 52:383-9. doi:10.1136/gut.52.3.383
109. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol (1998) 10:245-251.
110. Brandtzaeg P, Halstensen TS. Immunology and immunopathology of tonsils. Adv Otorhinolaryngol (1992) 47:64-75.
111. Suzuki K, Grigorova I, Phan TG, Kelly LM, Cyster JG. Visualizing B cell capture of cognate antigen from follicular dendritic cells. J Exp Med (2009) 206:1485-93. doi:10.1084/jem.20090209
112. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol (2011) 29:621-63. doi:10.1146/annurev-immunol-031210-101400
113. Spencer J, Klavinskis LS, Fraser LD. The human intestinal IgA response; burning questions. Front Immunol (2012) 3:108. doi:10.3389/fimmu.2012.00108
114. Bergqvist P, Stensson A, Lycke NY, Bemark M. T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J Immunol (2010) 184:3545-53. doi:10.4049/jimmunol.0901895
115. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (2000) 288:2222-6. doi:10.1126/science.288.5474.2222
116. Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology (2005) 115:153-62. doi:10.1111/j.1365-2567.2005.02159.x
117. Zhang Y, Meyer-Hermann M, George LA, Figge MT, Khan M, Goodall M, et al. Germinal center B cells govern their own fate via antibody feedback. J Exp Med (2013) 210:457-64. doi:10.1084/jem.20120150
118. Severson KM, Mallozzi M, Driks A, Knight KL. B cell development in GALT: role of bacterial superantigen-like molecules. J Immunol (2010) 184:6782-9. doi:10.4049/jimmunol.1000155
119. Rangel-Moreno J, Moyron-Quiroz JE, Carragher DM, Kusser K, Hartson L, Moquin A, et al. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity (2009) 30:731-43. doi:10.1016/j.immuni.2009.03.014
120. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol (1989) 1:75-84. doi:10.1093/intimm/1.1.75
121. Sindhava VJ, Bondada S. Multiple regulatory mechanisms control B-1 B cell activation. Front Immunol (2012) 3:372. doi:10.3389/fimmu.2012.00372
122. Bos NA, Bun JC, Popma SH, Cebra ER, Deenen GJ, van der Cammen MJ, et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun (1996) 64:616-23.
123. Roy B, Agarwal S, Brennecke AM, Krey M, Pabst O, Düber S, et al. B-1 cell subpopulations contribute differently to gut immunity. Eur J Immunol (2013). doi:10.1002/eji.201243070
124. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol (2003) 3:63-72. doi:10.1038/nri982
125. Suzuki K, Fagarasan S. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol (2008) 29:523-31. doi:10.1016/j.it.2008.08.001
126. Brandtzaeg P, Baekkevold ES, Morton HC. From B to A the mucosal way. Nat Immunol (2001) 2:1093-4. doi:10.1038/ni1201-1093
127. Boursier L, Farstad IN, Mellembakken JR, Brandtzaeg P, Spencer J. IgVH gene analysis suggests that peritoneal B cells do not contribute to the gut immune system in man. Eur J Immunol (2002) 32:2427-36. doi:10.1002/1521-4141(200209)32:9<2427::AID-IMMU2427>3.0.CO;2-P
128. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-. J Exp Med (2011) 208:67-80. doi:10.1084/jem.20101499
129. Bouvet JP, Fischetti VA. Diversity of antibody-mediated immunity at the mucosal barrier. Infect Immun (1999) 67:2687-91.
130. Husband AJ. Kinetics of extravasation and redistribution of IgA-specific antibody-containing cells in the intestine. J Immunol (1982) 128:1355-9.
131. Brandtzaeg P, Baklien K. Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol (1976) 11(Suppl 36):1-45.
132. Farstad IN, Carlsen H, Morton HC, Brandtzaeg P. Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics. Immunology (2000) 101:354-63. doi:10.1046/j.1365-2567.2000.00118.x
133. Yuvaraj S, Dijkstra G, Burgerhof JG, Dammers PM, Stoel M, Visser A, et al. Evidence for local expansion of IgA plasma cell precursors in human ileum. J Immunol (2009) 183:4871-8. doi:10.4049/jimmunol.0901315
134. Di Niro R, Mesin L, Raki M, Zheng NY, Lund-Johansen F, Lundin KE, et al. Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J Immunol (2010) 185:5377-83. doi:10.4049/jimmunol.1001587
135. Pinto D, Montani E, Bolli M, Garavaglia G, Sallusto F, Lanzavecchia A, et al. A functional BCR in human IgA and IgM plasma cells. Blood (2013) 121:4110-4. doi:10.1182/blood-2012-09-459289
136. Mesin L, Di Niro R, Thompson KM, Lundin KE, Sollid LM. Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J Immunol (2011) 187:2867-74. doi:10.4049/jimmunol.1003181
137. Huard B, McKee T, Bosshard C, Durual S, Matthes T, Myit S, et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest (2008) 118:2887-95. doi:10.1172/JCI33760
138. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 80:6019-23. doi:10.1073/pnas.80.19.6019
139. Thrane PS, Sollid LM, Haanes HR, Brandtzaeg P. Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand J Immunol (1992) 35:43-51. doi:10.1111/j.1365-3083.1992.tb02832.x
140. Newman RA, Ormerod MG, Greaves MF. The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes. Clin Exp Immunol (1980) 41:478-86.
141. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med (2004) 200:805-9. doi:10.1084/jem.20041069
142. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol (2004) 172:1118-24.
143. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL, et al. B cell receptor signal strength determines B cell fate. Nat Immunol (2004) 5:317-27. doi:10.1038/ni1036
144. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol (2008) 1:11-22. doi:10.1038/mi.2007.6
145. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 122:107-18. doi:10.1016/j.cell.2005.05.007
146. Crabbé PA, Nash DR, Bazin H, Eyssen H, Heremans JF. Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest (1970) 22:448-57.
147. Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 12:696-708. doi:10.1038/nri3299
148. Spencer SP, Belkaid Y. Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. Curr Opin Immunol (2012) 24:379-84. doi:10.1016/j.coi.2012.07.006
149. Lanning DK, Rhee KJ, Knight KL. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol (2005) 26:419-25. doi:10.1016/j.it.2005.06.001
150. Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol (2005) 175:3469-73.
151. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun (1995) 63:3904-13.
152. Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol Immunol (1995) 39:555-62.
153. Bos NA, Jiang HQ, Cebra JJ. T cell control of the gut IgA response against commensal bacteria. Gut (2001) 48:762-4. doi:10.1136/gut.48.6.762
154. Talham GL, Jiang HQ, Bos NA, Cebra JJ. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun (1999) 67:1992-2000.
155. Jiang H-Q, Bos NA, Cebra JJ. Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups. Infect Immun (2001) 69:3611-7. doi:10.1128/IAI.69.6.3611-3617.2001
156. Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe (2007) 2:328-39. doi:10.1016/j.chom.2007.09.013
157. Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 328:1705-9. doi:10.1126/science.1188454
158. Hansen J, Gulati A, Sartor RB. The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol (2010) 26:564-71. doi:10.1097/MOG.0b013e32833f1195
159. Kamada N, Seo SU, Chen GY, and Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 13:321-35. doi:10.1038/nri3430
160. Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, et al. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest (2011) 121:1946-55. doi:10.1172/JCI44447
161. Di Niro R, Mesin L, Zheng NY, Stamnaes J, Morrissey M, Lee JH, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 18:441-5. doi:10.1038/nm.2656
162. Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M, et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J Exp Med (2012) 209:2079-97. doi:10.1084/jem.20120127
163. Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol (2011) 23:473-80. doi:10.1016/j.coi.2011.07.010
164. Rogosch T, Kerzel S, HoβK, Hoersch G, Zemlin C, Heckmann M, et al. IgA response in preterm neonates shows little evidence of antigen-driven selection. J Immunol (2012) 189:5449-56. doi:10.4049/jimmunol.1103347
165. Nogueira RD, Sesso ML, Borges MC, Mattos-Graner RO, Smith DJ, Ferriani VP. Salivary IgA antibody responses to Streptococcus mitis and Streptococcus mutans in preterm and fullterm newborn children. Arch Oral Biol (2012) 57:647-53. doi:10.1016/j.archoralbio.2011.11.011
166. Dunn-Walters DK, Hackett M, Boursier L, Ciclitira PJ, Morgan P, Challacombe SJ, et al. Characteristics of human IgA and IgM genes used by plasma cells in the salivary gland resemble those used in duodenum but not those used in the spleen. J Immunol (2000) 164:1595-601.
167. Stoel M, Evenhuis WN, Kroese FG, Bos NA. Rat salivary gland reveals a more restricted IgA repertoire than ileum. Mol Immunol (2008) 45:719-27. doi:10.1016/j.molimm.2007.07.001
168. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol (2011) 12:24-34.
169. Wang NS, McHeyzer-Williams LJ, Okitsu SL, Burris TP, Reiner SL, McHeyzer-Williams MG. Divergent transcriptional programming of class-specific B cell memory by T-bet and RORα. Nat Immunol (2012) 13:604-11. doi:10.1038/ni.2294
170. Xu Z, Zan H, Pone EJ, Mai T, Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol (2012) 12:517-31. doi:10.1038/nri3216
171. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 102:553-63. doi:10.1016/S0092-8674(00)00078-7
172. Berkowska MA, Driessen GJ, Bikos V, Grosserichter-Wagener C, Stamatopoulos K, Cerutti A, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood (2011) 118:2150-8. doi:10.1182/blood-2011-04-345579
173. Lundell AC, Björnsson V, Ljung A, Ceder M, Johansen S, Lindhagen G, et al. Infant B cell memory differentiation and early gut bacterial colonization. J Immunol (2012) 188:4315-22. doi:10.4049/jimmunol.1103223
174. Bergqvist P, Stensson A, Hazanov L, Holmberg A, Mattsson J, Mehr R, et al. Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses. Mucosal Immunol (2013) 6:122-35. doi:10.1038/mi.2012.56
175. Lindner C, Wahl B, Föhse L, Suerbaum S, Macpherson AJ, Prinz I, et al. Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J Exp Med (2012) 209:365-77. doi:10.1084/jem.20111980
176. Pabst O. New concepts in the generation and functions of IgA. Nat Rev Immunol (2012) 12:821-32. doi:10.1038/nri3322
177. Slack E, Balmer ML, Fritz JH, Hapfelmeier S. Functional flexibility of intestinal IgA - broadening the fine line. Front Immunol (2012) 3:100. doi:10.3389/fimmu.2012.00100
178. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology (2009) 136:65-80. doi:10.1053/j.gastro.2008.10.080
179. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 10:159-69. doi:10.1038/nri2710
180. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacteria and host interactions in the gut epithelial barrier. Nat Chem Biol (2011) 8:36-45. doi:10.1038/nchembio.741
181. Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol (2011) 11:187-200. doi:10.1038/nri2918
182. Sansonetti PJ. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol (2011) 4:8-14. doi:10.1038/mi.2010.77
183. Stuart LM, Paquette N, Boyer L. Effector-triggered versus pattern-triggered immunity: how animals sense pathogens. Nat Rev Immunol (2013) 13:199-206. doi:10.1038/nri3398
184. Srinivasan N. Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Innate Immun (2010) 16:391-404. doi:10.1177/1753425909357577
185. Kamada N, Chen G, and Núñez G. A complex microworld in the gut: harnessing pathogen-commensal relations. Nat Med (2012) 18:1190-1. doi:10.1038/nm.2900
186. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science (2012) 336:1325-9. doi:10.1126/science.1222195
187. van der Waaij LA, Limburg PC, Mesander G, van der Waaij D. In vivo IgA coating of anaerobic bacteria in human faeces. Gut (1996) 38:348-54. doi:10.1136/gut.38.3.348
188. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, Calabuig M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol (2010) 10:63. doi:10.1186/1471-2180-10-63
189. Reikvam DH, Derrien M, Islam R, Erofeev A, Grcic V, Sandvik A, et al. Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice. Eur J Immunol (2012) 42:2959-70. doi:10.1002/eji.201242543
190. Kawamoto S, Tran TH, Maruya M, Suzuki K, Doi Y, Tsutsui Y, et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science (2012) 336:485-9. doi:10.1126/science.1217718
191. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol (2004) 4:478-85. doi:10.1038/nri1373
192. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med (2006) 203:21-6. doi:10.1084/jem.20052093
193. Tsuruta T, Inoue R, Nojima I, Tsukahara T, Hara H, Yajima T. The amount of secreted IgA may not determine the secretory IgA coating ratio of gastrointestinal bacteria. FEMS Immunol Med Microbiol (2009) 56:185-9. doi:10.1111/j.1574-695X
194. Robles Alonso V, Guarner F. Linking the gut microbiota to human health. Br J Nutr (2013) 109(Suppl 2):S21-6. doi:10.1017/S0007114512005235
195. van der Waaij LA, Kroese FG, Visser A, Nelis GF, Westerveld BD, Jansen PL, et al. Immunoglobulin coating of faecal bacteria in inflammatory bowel disease. Eur J Gastroenterol Hepatol (2004) 16:669-74. doi:10.1097/01.meg.0000108346.41221.19
196. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med (2011) 17:1585-93. doi:10.1038/nm.2505
197. Chorny A, Cerutti A. A gut triumvirate rules homeostasis. Nat Med (2011) 17:1549-50. doi:10.1038/nm.2592
198. Brandtzaeg P, Nilssen DE. Mucosal aspects of primary B-cell deficiency and gastrointestinal infections. Curr Opin Gastroenterol (1995) 11:532-40. doi:10.1097/00001574-199511000-00012
199. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine (2007) 25:5467-84.
200. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol (2012) 12:592-605. doi:10.1038/nri3251